Opsynvi Launch Gulf

About the Event

The event is organized to support the commercial launch of OPSYNVI®, a newly launched treatment for pulmonary arterial hypertension (PAH). The event will provide a scientific platform to share relevant clinical evidence and data related to OPSYNVI®. Scientific leaders will be engaged to provide expert perspectives and facilitate scientific exchange with the audience. The event aims to enhance understanding of the evolving PAH treatment landscape and the scientific evidence supporting OPSYNVI®. The overall objective is to support appropriate scientific education and product knowledge following the launch. DET Permit + Ticketing